BCI
RDY icon

Brinker Capital Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Brinker Capital Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$814K Sell
56,160
-21,889
-28% -$295K 0.01% 1263
2026
Q1 		$1.08M Sell
78,049
-30,979
-28% -$431K 0.01% 1080
2025
Q4 		$1.53M Buy
109,028
+28,597
+36% +$401K 0.01% 993
2025
Q3 		$1.12M Sell
80,431
-36,922
-31% -$531K 0.01% 1163
2025
Q2 		$1.76M Buy
117,353
+32,664
+39% +$466K 0.02% 862
2025
Q1 		$1.12M Sell
84,689
-9,593
-10% -$132K 0.01% 1021
2024
Q4 		$1.49M Sell
94,282
-8,338
-8% -$125K 0.01% 839
2024
Q3 		$1.63M Buy
102,620
+30,960
+43% +$498K 0.02% 795
2024
Q2 		$1.09M Sell
71,660
-2,590
-3% -$37.1K 0.01% 948
2024
Q1 		$1.09M Buy
74,250
+1,590
+2% +$23.2K 0.01% 949
2023
Q4 		$1.02M Buy
72,660
+34,230
+89% +$458K 0.01% 934
2023
Q3 		$514K Sell
38,430
-620
-2% -$8.39K 0.01% 1195
2023
Q2 		$493K Sell
39,050
-56,825
-59% -$663K 0.01% 1214
2023
Q1 		$1.09M Buy
+95,875
New +$1.03M 0.01% 835
2021
Q4 		– Sell
-195,290
Closed -$2.87M – 1425
2021
Q3 		$2.87M Hold
195,290
– – 0.05% 432
2021
Q2 		$2.87M Buy
195,290
+27,430
+16% +$384K 0.04% 489
2021
Q1 		$2.06M Buy
+167,860
New +$2.16M 0.03% 506
2020
Q4 		– Sell
-70,765
Closed -$987K – 1160
2020
Q3 		$987K Buy
+70,765
New +$843K 0.02% 690

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brinker Capital Investments's RDY Position: Q2 2026 in Review

Brinker Capital Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 28% in Q2 2026, selling an estimated $295K and leaving 56,160 shares worth $814K. The position accounts for 0.01% of the portfolio, ranked #1263.

Brinker Capital Investments first reported a position in RDY in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.87M in Q3 2021. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Brinker Capital Investments held 56,160 shares of Dr. Reddy's Laboratories worth $814K as of Q2 2026.
  • Brinker Capital Investments sold 21,889 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $295K.
  • Dr. Reddy's Laboratories made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1263 holding.
  • Brinker Capital Investments first reported a position in Dr. Reddy's Laboratories in Q3 2020 and has held it in 18 quarters since.
  • Brinker Capital Investments's Dr. Reddy's Laboratories position peaked at $2.87M in Q3 2021.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.